1. Home
  2. SNDX vs RSI Comparison

SNDX vs RSI Comparison

Compare SNDX & RSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • RSI
  • Stock Information
  • Founded
  • SNDX 2005
  • RSI 2012
  • Country
  • SNDX United States
  • RSI United States
  • Employees
  • SNDX N/A
  • RSI N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • RSI Services-Misc. Amusement & Recreation
  • Sector
  • SNDX Health Care
  • RSI Consumer Discretionary
  • Exchange
  • SNDX Nasdaq
  • RSI Nasdaq
  • Market Cap
  • SNDX 1.1B
  • RSI 1.2B
  • IPO Year
  • SNDX 2016
  • RSI N/A
  • Fundamental
  • Price
  • SNDX $13.08
  • RSI $15.02
  • Analyst Decision
  • SNDX Strong Buy
  • RSI Buy
  • Analyst Count
  • SNDX 10
  • RSI 9
  • Target Price
  • SNDX $36.20
  • RSI $13.14
  • AVG Volume (30 Days)
  • SNDX 2.6M
  • RSI 1.7M
  • Earning Date
  • SNDX 02-25-2025
  • RSI 03-05-2025
  • Dividend Yield
  • SNDX N/A
  • RSI N/A
  • EPS Growth
  • SNDX N/A
  • RSI N/A
  • EPS
  • SNDX N/A
  • RSI N/A
  • Revenue
  • SNDX $16,000,000.00
  • RSI $863,767,000.00
  • Revenue This Year
  • SNDX N/A
  • RSI $33.53
  • Revenue Next Year
  • SNDX $14.15
  • RSI $13.01
  • P/E Ratio
  • SNDX N/A
  • RSI N/A
  • Revenue Growth
  • SNDX N/A
  • RSI 30.31
  • 52 Week Low
  • SNDX $12.06
  • RSI $4.72
  • 52 Week High
  • SNDX $25.34
  • RSI $15.68
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 41.29
  • RSI 63.24
  • Support Level
  • SNDX $12.40
  • RSI $14.90
  • Resistance Level
  • SNDX $13.16
  • RSI $15.68
  • Average True Range (ATR)
  • SNDX 0.65
  • RSI 0.66
  • MACD
  • SNDX 0.10
  • RSI 0.07
  • Stochastic Oscillator
  • SNDX 39.38
  • RSI 72.73

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About RSI Rush Street Interactive Inc.

Rush Street Interactive Inc is an online gaming and entertainment company that focuses primarily on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.

Share on Social Networks: